COVAXIN developed by Bharat Biotech has equivalent immunogenicity against the UK-variant & circulating strains of SARS-COV-2 in India : DG, ICMR

Union Health Ministry Press briefing on the actions taken, preparedness and updates on COVID19 at National Media Centre:

  • No. of vaccine doses administered- 25,07,556
  • Active cases less than 1.75 lakhs
  • Daily no. of deaths less than 125
  • Cumulative positivity rate, 5.51% and declining
  • 2 States/UTs with more than 40,000 cases contribute 67%
  • India’s daily cases are continuously declining. The graph shows the 7 day moving average of New Cases
  • The global comparison between India and several countries, India is fastest to reach 1 million vaccination
  • COVAXIN developed by Bharat Biotech has equivalent immunogenicity against the UK-variant & circulating strains of SARS-COV-2 in India

Leave a Reply